MARKET

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ
3.420
+0.060
+1.79%
After Hours: 3.470 +0.05 +1.46% 18:17 01/17 EST
OPEN
3.370
PREV CLOSE
3.360
HIGH
3.445
LOW
3.320
VOLUME
18.51K
TURNOVER
--
52 WEEK HIGH
4.708
52 WEEK LOW
1.001
MARKET CAP
29.90M
P/E (TTM)
-1.6311
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATHE last week (0106-0110)?
Weekly Report · 4d ago
Alterity CEO says ‘filled with optimism for 2025’
TipRanks · 01/09 12:35
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
Barchart · 01/09 06:25
Weekly Report: what happened at ATHE last week (1230-0103)?
Weekly Report · 01/06 11:23
Weekly Report: what happened at ATHE last week (1223-1227)?
Weekly Report · 12/30/2024 11:17
Weekly Report: what happened at ATHE last week (1216-1220)?
Weekly Report · 12/23/2024 11:23
Weekly Report: what happened at ATHE last week (1209-1213)?
Weekly Report · 12/16/2024 11:24
Alterity Therapeutics Price Target Announced at $8.00/Share by Maxim Group
Dow Jones · 12/12/2024 16:53
More
About ATHE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Webull offers Alterity Therapeutics Ltd (ADR) stock information, including NASDAQ: ATHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHE stock methods without spending real money on the virtual paper trading platform.